What in‑network insulin pen should I order for a patient whose prescribed insulin pen is out‑of‑network?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 23, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Switch to Insulin Vials and Syringes as the Most Cost-Effective Alternative

When a patient's insulin pen is out-of-network, immediately switch to insulin vials with syringes—this is the most affordable and universally covered option that maintains the same insulin formulation. 1, 2, 3

Practical Algorithm for Ordering

Step 1: Identify the Exact Insulin Type

  • Determine which specific insulin the patient needs (e.g., lispro, aspart, glargine, NPH)
  • The insulin compound itself matters more than the delivery device

Step 2: Order the Vial Formulation

  • Request the same insulin in vial form rather than pen form
  • Most insulins are available in both formats, though vials are significantly cheaper 1
  • Example cost differences from 2020 data:
    • Lispro U-100 vial: $330 per 1,000 units
    • Lispro U-100 prefilled pen: $424 per 1,000 units
    • Human regular U-100 vial: $165 per 1,000 units 1

Step 3: Prescribe Appropriate Syringes

  • 1 mL syringe (holds up to 100 units) for most patients
  • 0.5 mL syringe (holds up to 50 units) for moderate doses
  • 0.3 mL syringe (holds up to 30 units) for small doses or children 3
  • Specify permanently attached needle syringes (better accuracy, less dead space) 4
  • Recommend 6 mm needle length for most adults 5

Step 4: Consider Lower-Cost Insulin Alternatives if Needed

If even vials are too expensive, consider these options in order:

  1. Human insulin (NPH or regular): Available at approximately $25/vial at Walmart 1

    • Effective for many type 2 diabetes patients
    • Requires education on different timing/dosing compared to analogs 6, 7
  2. Authorized generics/biosimilars:

    • Lispro follow-on product: $157 per 1,000 units (vial) vs. $330 for brand 1
    • Glargine follow-on product available 1
  3. Manufacturer assistance programs:

    • Eli Lilly: $35/month insulin program 7
    • Novo Nordisk: My$99Insulin program 7
    • Sanofi: ValYou Savings Program at $99/month 7

Critical Patient Education Points

When switching from pen to syringe 4, 5:

  • Air injection technique: Draw air equal to insulin dose, inject into vial first, then withdraw insulin
  • Bubble removal: Tap syringe barrel to bring bubbles to surface before injection
  • Syringe-insulin concentration matching: Ensure U-100 syringe for U-100 insulin (critical safety issue)
  • Injection technique: Use 90-degree angle with 6 mm needle for most adults
  • Single use: Syringes designed for one-time use (though may be reused by same patient in resource-limited settings with proper storage) 3

Common Pitfalls to Avoid

  • Never mix syringe and insulin concentrations (e.g., U-40 syringe with U-100 insulin)—this causes dangerous dosing errors 4
  • Don't assume patient knows syringe technique—provide hands-on demonstration 4
  • Avoid detachable needle syringes—permanently attached needles are more accurate 4
  • Don't prescribe U-500 insulin without U-500-specific syringes (approved July 2016) 6

Special Populations Requiring Pens

Only maintain pen prescription (and work with insurance/patient assistance) if patient has:

  • Severe vision impairment preventing accurate syringe reading 2, 3
  • Significant dexterity issues (arthritis, tremor, stroke) preventing syringe manipulation 2, 3
  • Cognitive impairment where pen's simpler mechanism is safer

For these patients, contact manufacturer patient assistance programs directly rather than switching to syringes 7.

Insurance Navigation

  • Vials typically have broader formulary coverage than pens
  • If vial also denied, request formulary exception citing medical necessity
  • Human insulins (NPH, regular) are nearly universally covered 1, 7

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.